$PVCT·4

PROVECTUS BIOPHARMACEUTICALS, INC. · Jul 1, 10:22 AM ET

PROVECTUS BIOPHARMACEUTICALS, INC. 4

4 · PROVECTUS BIOPHARMACEUTICALS, INC. · Filed Jul 1, 2014

Insider Transaction Report

Form 4
Period: 2014-06-28
CULPEPPER PETER R
Chief Financial Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2014-06-28$1.25/sh+100,000$125,0001,112,332 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2014-06-28100,0000 total
    Exercise: $1.25From: 2004-06-28Exp: 2014-06-28Common Stock (100,000 underlying)
Holdings
  • Common Stock

    (indirect: By 401(k))
    121,000

Documents

1 file
  • 4
    doc1.xmlPrimary

    FORM 4